We used a human wrist coil and obtained T2-weighted images (T2WI: fast spin echo [FSE], repetition time/echo time [TR/TE] = 4,375/100), fluid-attenuated inversion recovery (FLAIR: fast inversion recovery [FIR], TR/TE = 8,292/78), and T1-weighted images (T1WI: spin-echo [SE], TR/TE = 400/15) with and without intravenous (IV) gadodiamide (0.2 mL/kg, OMNISCAN, GE Healthcare Pharma, Tokyo, Japan) in the transverse, sagittal, and dorsal planes
Kreider RB, Ferreira MP, Greenwood M, Wilson M, Almada AL
Lilly's Double-Beat Widens the GLP-1 GapAnd a New Pill Could Make It Permanent The $63-billion GLP-1 agonist industry is forecast to triple in the coming decade, so it's no surprise that pharmaceuticals companies of all sizes are scrambling to get in on the action
After eliminating duplicates, 51 targets with standardized names were acquired
A review of incretin therapies approved and in late-stage development for overweight and obesity management